Ma B, Wells A, Wei L, Zheng J. Prostate cancer liver metastasis: dormancy and resistance to therapy. Semin Cancer Biol. 2021;71:2–9.
Article CAS PubMed Google Scholar
Xu M, Zhang T, Xia R, Wei Y, Wei X. Targeting the tumor stroma for cancer therapy. Mol Cancer. 2022;21:208–43.
Article PubMed PubMed Central Google Scholar
Yang F, Ning Z, Ma L, Liu W, Shao C, Shu Y, et al. Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts. Mol Cancer. 2017;16:148–57.
Article PubMed PubMed Central Google Scholar
Jang I, Beningo KA. Integrins, CAFs and mechanical forces in the progression of cancer. Cancers. 2019;11:721.
Article CAS PubMed PubMed Central Google Scholar
Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174–86.
Article CAS PubMed PubMed Central Google Scholar
Ivan M, Fishel ML, Tudoran OM, Pollok KE, Wu X, Smith PJ. Hypoxia signaling: challenges and opportunities for cancer therapy. Semin Cancer Biol. 2022;85:185–95.
Article CAS PubMed Google Scholar
Tian X, Shen H, Li Z, Wang T, Wang S. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment. J Hematol Oncol. 2019;12:84–101.
Article PubMed PubMed Central Google Scholar
Shao C, Yang F, Miao S, Liu W, Wang C, Shu Y, et al. Role of hypoxia-induced exosomes in tumor biology. Mol Cancer. 2018;17:120–8.
Article PubMed PubMed Central Google Scholar
Meng W, Hao Y, He C, Li L, Zhu G. Exosome-orchestrated hypoxic tumor microenvironment. Mol Cancer. 2019;18:57–70.
Article PubMed PubMed Central Google Scholar
Yu W, Hurley J, Roberts D, Chakrabortty SK, Enderle D, Noerholm M, et al. Exosome-based liquid biopsies in cancer: opportunities and challenges. Ann Oncol. 2021;32:466–77.
Article CAS PubMed Google Scholar
Dinh P-UC, Paudel D, Brochu H, Popowski KD, Gracieux MC, Cores J, et al. Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. Nat Commun. 2020;11:1064.
Article CAS PubMed PubMed Central ADS Google Scholar
Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia 2022;25:18–27.
Article CAS PubMed PubMed Central Google Scholar
Abu El Maaty MA, Terzic J, Keime C, Rovito D, Lutzing R, Yanushko D, et al. Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant progression. Sci Adv. 2022;8:eabo2295.
Article CAS PubMed PubMed Central Google Scholar
Bery F, Figiel S, Kouba S, Fontaine D, Guéguinou M, Potier-Cartereau M, et al. Hypoxia promotes prostate cancer aggressiveness by upregulating EMT-activator Zeb1 and SK3 channel expression. Int J Mol Sci. 2020;21:4786.
Article CAS PubMed PubMed Central Google Scholar
Garcia-Martin R, Wang G, Brandão BB, Zanotto TM, Shah S, Kumar Patel S, et al. MicroRNA sequence codes for small extracellular vesicle release and cellular retention. Nature 2022;601:446–51.
Article CAS PubMed ADS Google Scholar
Fan J, Bellon M, Ju M, Zhao L, Wei M, Fu L, et al. Clinical significance of FBXW7 loss of function in human cancers. Mol Cancer. 2022;21:87–112.
Article CAS PubMed PubMed Central Google Scholar
Gstalder C, Liu D, Miao D, Lutterbach B, DeVine AL, Lin C, et al. Inactivation of Fbxw7 Impairs dsRNA sensing and confers resistance to PD-1 blockade. Cancer Discov. 2020;10:1296–311.
Article CAS PubMed PubMed Central Google Scholar
Yeh C-H, Bellon M, Nicot C. FBXW7: a critical tumor suppressor of human cancers. Mol Cancer. 2018;17:115–33.
Article PubMed PubMed Central Google Scholar
Dong B, Jaeger AM, Hughes PF, Loiselle DR, Hauck JS, Fu Y, et al. Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1. Sci Transl Med. 2020;12:eabb5647.
Article CAS PubMed PubMed Central Google Scholar
Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18:157.
Article PubMed PubMed Central Google Scholar
Wang B, Zhao Q, Zhang Y, Liu Z, Zheng Z, Liu S, et al. Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy. J Exp Clin Cancer Res. 2021;40:24.
Article PubMed PubMed Central Google Scholar
Hapke RY, Haake SM. Hypoxia-induced epithelial to mesenchymal transition in cancer. Cancer Lett. 2020;487:10–20.
Article CAS PubMed PubMed Central ADS Google Scholar
Shan G, Gu J, Zhou D, Li L, Cheng W, Wang Y, et al. Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-β signaling pathway. Exp Mol Med. 2020;52:1809–22.
Article CAS PubMed PubMed Central Google Scholar
Jia D, Zhou Z, Kwon O-J, Zhang L, Wei X, Zhang Y, et al. Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity. Nat Commun. 2022;13:6828.
Article CAS PubMed PubMed Central ADS Google Scholar
Long J, Liu B, Yao Z, Weng H, Li H, Jiang C, et al. miR-500a-3p is a potential prognostic biomarker in hepatocellular carcinoma. Int J Gen Med. 2022;15:1891–9.
Article CAS PubMed PubMed Central Google Scholar
Jiang C, Long J, Liu B, Xu M, Wang W, Xie X, et al. miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2017;36:99–111.
Article PubMed PubMed Central Google Scholar
Liu Y, Tang W, Ren L, Liu T, Yang M, Wei Y, et al. Activation of miR-500a-3p/CDK6 axis suppresses aerobic glycolysis and colorectal cancer progression. J Transl Med. 2022;20:106–17.
Article CAS PubMed PubMed Central Google Scholar
Lin H, Zhang L, Zhang C, Liu P. Exosomal MiR-500a-3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancer. J Cell Mol Med. 2020;24:8930–41.
Article CAS PubMed PubMed Central Google Scholar
Kmiecik SW, Mayer MP. Molecular mechanisms of heat shock factor 1 regulation. Trends Biochem Sci. 2022;47:218–34.
Article CAS PubMed Google Scholar
Kourtis N, Moubarak RS, Aranda-Orgilles B, Lui K, Aydin IT, Trimarchi T, et al. FBXW7 modulates cellular stress response and metastatic potential through HSF1 post-translational modification. Nat Cell Biol. 2015;17:322–32.
Article PubMed PubMed Central Google Scholar
Jia G, Wu W, Chen L, Yu Y, Tang Q, Liu H, et al. HSF1 is a novel prognostic biomarker in high-risk prostate cancer that correlates with ferroptosis. Discov Oncol. 2023;14:107.
Comments (0)